Clinical Trials Browser

Phase 1/2 × OTHER × Drug Resistant Epilepsy × Clear all

NCT02332655 2022-03-02

Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome

Phase 1/2 Completed

5 enrolled 8 charts

Drug Resistant Epilepsy, Sturge-Weber Syndrome